Optimized MRI Contrast Agent

  • ChemPubSoc Europe Logo
  • Author: Chemistry – A European Journal
  • Published Date: 21 April 2019
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Optimized MRI Contrast Agent

Related Societies

Contrast agents for magnetic resonance imaging (MRI) usually consist of stable complexes of paramagnetic lanthanide ions. In particular, Gd complexes are widely used for clinical diagnosis and preclinical studies. In contrast, chemical exchange saturation transfer (CEST) agents (Eu, Tm or Yb complexes) are only used in preclinical MRI.


Lorenzo Tei, University of Eastern Piedmont, Alessandria, Italy, Daniela Delli Castelli, University of Turin, Italy, and colleagues have synthesized a new macrocyclic ligand with improved contrast properties. The ligand, HPDO3MA [(R,R,R,R)‐10‐(2‐hydroxypropyl)‐α,α′,α′′‐trimethyl‐1,4,7,10‐tetraazacyclododecane‐1,4,7‐triacetic acid] (pictured), was prepared from a carbobenzyloxy (Cbz)-protected 1,4,7,10-tetraazacyclododecane in four steps. The structure was derived from two similar ligands: the clinically approved HPDO3A (10‐(2‐hydroxypropyl)‐1,4,7,10‐tetraazacyclododecane‐1,4,7‐triacetic acid) and DOTMA (1R,4R,7R,10R)‐α,α′,α′′,α′′′‐tetramethyl‐1,4,7,10‐tetraazacyclododecane‐1,4,7,10‐tetraacetic acid).


The team observed a substantial increase in the relaxation efficiency of the Gd complex and a doubled sensitivity gain in the CEST effect compared with similar systems. Moreover, the complexes show a high kinetic inertness at physiological pH, higher than that of some clinically approved agents.

The results demonstrate how the properties of MRI probes can be optimized through relatively simple chemical modifications. Improving both kinetic stability and performance of MRI probes are significant steps towards the development of safer and more effective agents.


 

Article Views: 694

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH